Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Spina Bifida Occulta 1Neural Tube Defects 1Neoplasms 1Lipomyelomeningocele 1Cerebrospinal Fluid Leak 1Breast Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Prone Position × Clear all
NCT02237469 2022-12-21

HUGProne

University Hospital, Geneva

Unknown
280 enrolled
Breast

Breast Neoplasms

NCT01867268 2015-04-21

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

Tehran University of Medical Sciences

Phase 2 Unknown
144 enrolled

Lipomyelomeningocele, Neoplasms, Neural Tube Defects, Spina Bifida Occulta, Cerebrospinal Fluid Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡